免疫监视
免疫系统
免疫原性
免疫学
生物
抗原
疾病
佐剂
癌细胞
免疫原性细胞死亡
程序性细胞死亡
抗原性
获得性免疫系统
癌症
免疫疗法
医学
细胞凋亡
遗传学
病理
作者
Lorenzo Galluzzi,Aitziber Buqué,Oliver Kepp,Laurence Zitvogel,Guido Kroemer
出处
期刊:Nature Reviews Immunology
[Springer Nature]
日期:2016-10-17
卷期号:17 (2): 97-111
被引量:2242
摘要
Immunogenicity depends on two key factors: antigenicity and adjuvanticity. The presence of exogenous or mutated antigens explains why infected cells and malignant cells can initiate an adaptive immune response provided that the cells also emit adjuvant signals as a consequence of cellular stress and death. Several infectious pathogens have devised strategies to control cell death and limit the emission of danger signals from dying cells, thereby avoiding immune recognition. Similarly, cancer cells often escape immunosurveillance owing to defects in the molecular machinery that underlies the release of endogenous adjuvants. Here, we review current knowledge on the mechanisms that underlie the activation of immune responses against dying cells and their pathophysiological relevance.
科研通智能强力驱动
Strongly Powered by AbleSci AI